As previously noted, we also found that the majority of genes involved in the PI3K/AKT pathway, such as AKT1, AKT2, AKT3, and BTK (Fig. 2a–c, Table 3) were upregulated in the AML-RR group compared with the AML-CR group. The gene discussed is AKT2; the disease is acute myeloid leukemia.